These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36010558)

  • 21. AKAP1 contributes to impaired mtDNA replication and mitochondrial dysfunction in podocytes of diabetic kidney disease.
    Feng J; Chen Z; Ma Y; Yang X; Zhu Z; Zhang Z; Hu J; Liang W; Ding G
    Int J Biol Sci; 2022; 18(10):4026-4042. PubMed ID: 35844803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of mitochondrial quality control by Sirtuins on the treatment of type 2 diabetes and diabetic kidney disease.
    Xu J; Kitada M; Koya D
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165756. PubMed ID: 32147421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondria-targeted drugs for diabetic kidney disease.
    Mima A
    Heliyon; 2022 Feb; 8(2):e08878. PubMed ID: 35265754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Loss of Mitochondrial Quality Control in Diabetic Kidney Disease.
    Dai W; Lu H; Chen Y; Yang D; Sun L; He L
    Front Cell Dev Biol; 2021; 9():706832. PubMed ID: 34422828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease.
    Zhan M; Usman IM; Sun L; Kanwar YS
    J Am Soc Nephrol; 2015 Jun; 26(6):1304-21. PubMed ID: 25270067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcription of MRPL12 regulated by Nrf2 contributes to the mitochondrial dysfunction in diabetic kidney disease.
    Gu X; Liu Y; Wang N; Zhen J; Zhang B; Hou S; Cui Z; Wan Q; Feng H
    Free Radic Biol Med; 2021 Feb; 164():329-340. PubMed ID: 33444714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crosstalk Between Lipids and Mitochondria in Diabetic Kidney Disease.
    Ducasa GM; Mitrofanova A; Fornoni A
    Curr Diab Rep; 2019 Nov; 19(12):144. PubMed ID: 31754839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of TLR4 on PGC-1
    Yuan S; Liu X; Zhu X; Qu Z; Gong Z; Li J; Xiao L; Yang Y; Liu H; Sun L; Liu F
    Oxid Med Cell Longev; 2018; 2018():6296802. PubMed ID: 29861832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine protects against diabetic kidney disease via promoting PGC-1α-regulated mitochondrial energy homeostasis.
    Qin X; Jiang M; Zhao Y; Gong J; Su H; Yuan F; Fang K; Yuan X; Yu X; Dong H; Lu F
    Br J Pharmacol; 2020 Aug; 177(16):3646-3661. PubMed ID: 31734944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NR4A1 Promotes Diabetic Nephropathy by Activating Mff-Mediated Mitochondrial Fission and Suppressing Parkin-Mediated Mitophagy.
    Sheng J; Li H; Dai Q; Lu C; Xu M; Zhang J; Feng J
    Cell Physiol Biochem; 2018; 48(4):1675-1693. PubMed ID: 30077998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial DNA: A New Predictor of Diabetic Kidney Disease.
    Huang Y; Chi J; Wei F; Zhou Y; Cao Y; Wang Y
    Int J Endocrinol; 2020; 2020():3650937. PubMed ID: 32733553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy.
    Czajka A; Ajaz S; Gnudi L; Parsade CK; Jones P; Reid F; Malik AN
    EBioMedicine; 2015 Jun; 2(6):499-512. PubMed ID: 26288815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondria in Diabetic Kidney Disease.
    Ahmad AA; Draves SO; Rosca M
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease.
    Ma L; Zhang L; Li J; Zhang X; Xie Y; Li X; Yang B; Yang H
    Mol Med; 2023 Oct; 29(1):148. PubMed ID: 37907885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Podocyte Injury in Diabetic Kidney Disease: A Focus on Mitochondrial Dysfunction.
    Liu S; Yuan Y; Xue Y; Xing C; Zhang B
    Front Cell Dev Biol; 2022; 10():832887. PubMed ID: 35321238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes.
    Coughlan MT; Nguyen TV; Penfold SA; Higgins GC; Thallas-Bonke V; Tan SM; Van Bergen NJ; Sourris KC; Harcourt BE; Thorburn DR; Trounce IA; Cooper ME; Forbes JM
    Clin Sci (Lond); 2016 May; 130(9):711-20. PubMed ID: 26831938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial quality control mechanisms as molecular targets in diabetic heart.
    Chang X; Li Y; Cai C; Wu F; He J; Zhang Y; Zhong J; Tan Y; Liu R; Zhu H; Zhou H
    Metabolism; 2022 Dec; 137():155313. PubMed ID: 36126721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility.
    Tan SM; Ziemann M; Thallas-Bonke V; Snelson M; Kumar V; Laskowski A; Nguyen TV; Huynh K; Clarke MV; Libianto R; Baker ST; Skene A; Power DA; MacIsaac RJ; Henstridge DC; Wetsel RA; El-Osta A; Meikle PJ; Wilson SG; Forbes JM; Cooper ME; Ekinci EI; Woodruff TM; Coughlan MT
    Diabetes; 2020 Jan; 69(1):83-98. PubMed ID: 31624141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes.
    Hinder LM; Sas KM; O'Brien PD; Backus C; Kayampilly P; Hayes JM; Lin CM; Zhang H; Shanmugam S; Rumora AE; Abcouwer SF; Brosius FC; Pennathur S; Feldman EL
    Sci Rep; 2019 Jan; 9(1):881. PubMed ID: 30696927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.